Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Chimerix Inc.

Start price
Target price
Perf. (%)
€1.19
24.06.23
€3.00
31.03.26
-31.00%
12.07.24

Could be very worthwhile Investment >20% year
BiotechBee 
24.06.23 50%
buy
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€38.49
24.06.23
€50.00
31.03.26
-38.56%
12.07.24

Could be very worthwhile Investment >20% year
BiotechBee 
24.06.23 50%
buy
Krystal Biotech

Start price
Target price
Perf. (%)
€105.00
24.06.23
€200.00
30.04.26
77.24%
12.07.24

Could be very worthwhile Investment >20% year
BiotechBee 
24.06.23 80%
buy
Madrigal Pharmaceuticals inc.

Start price
Target price
Perf. (%)
€214.90
24.06.23
€380.00
31.05.26
23.78%
12.07.24

Could be very worthwhile Investment >20% year
BiotechBee 
24.06.23 70%
buy
Prothena Corp. plc

Start price
Target price
Perf. (%)
€62.00
24.06.23
€90.00
31.03.26
-66.77%
11.07.24

Could be very worthwhile Investment >20% year
BiotechBee 
24.06.23 70%
buy
Voyager Therapeutics Inc

Start price
Target price
Perf. (%)
€10.60
24.06.23
€20.00
31.12.25
-30.42%
09.07.24

Could be very worthwhile Investment >20% year
BiotechBee 
24.06.23 70%
buy
Ocular Therapeutix Inc.

Start price
Target price
Perf. (%)
€5.70
07.09.22
€10.00
31.12.24
30.75%
12.07.24

Could be very worthwhile Investment >20% year
BiotechBee 
07.09.22 60%
buy
Xenon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€37.60
07.09.22
€50.00
31.12.24
-2.66%
10.07.24

Could be very worthwhile Investment >20% year
BiotechBee 
07.09.22 80%
buy
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€48.92
25.04.22
€120.00
03.02.25
-5.13%
12.07.24

Higher EBIT margin than peer group
Revenue growth >5% per year expected
EBIT growth >5% per year expected
High valuation
fabinator 
25.04.22 90%